Document:

Form of Third Supplemental Indenture

 Exhibit 4.1 
  
  
 TORCHMARK CORPORATION 
 as Issuer 
 and 
 THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. 
 as Trustee 
  
  
 Third Supplemental Indenture 
 Dated as
of June 30, 2009 
  
  
 9.25% Senior Notes due 2019 
  
  

 THIRD SUPPLEMENTAL INDENTURE 
 THIRD SUPPLEMENTAL INDENTURE, dated as of June 30, 2009 (this “Third Supplemental Indenture”) by and between Torchmark Corporation,
a Delaware corporation (the “Company”) and The Bank of New York Mellon Trust Company, N.A., a national banking association (successor in interest to J.P. Morgan Trust Company, N.A), as trustee under the Indenture (defined below)
(the “Trustee”). 
 WITNESSETH: 
 WHEREAS, the Company entered into that certain Indenture (the “Base Indenture” and, together with this Third Supplemental Indenture, the “Indenture”) dated as of February 1, 1987
with Morgan Guaranty Trust Company of New York, as trustee (“Morgan Guaranty”), providing for the issuance of Securities in series by the Company. 
 WHEREAS, the Company, Morgan Guaranty and The First National Bank of Chicago entered into that certain Instrument of Resignation, Appointment and Acceptance effective August 8, 1994, providing for the replacement
of Morgan Guaranty as trustee under the Base Indenture with The First National Bank of Chicago. 
 WHEREAS, the Company,
Bank One Trust Company, National Association (successor in interest to The First National Bank of Chicago) and The Bank of New York entered into that certain Supplemental Indenture dated December 14, 2001 (the “First Supplemental
Indenture”), (i) creating and authorizing a series of Securities under the Base Indenture entitled “6 1/4%
Senior Notes due 2006” (the “2006 Notes”) and (ii) appointing The Bank of New York as an additional trustee pursuant to Section 901(6) of the Base Indenture with respect to the 2006 Notes. 
 WHEREAS, Bank One Trust Company, National Association transferred its corporate trust business to J.P. Morgan Trust Company, National Association
effective November 15, 2003. 
 WHEREAS, the Company, The Bank of New York and The Bank of New York Trust Company, N.A. entered into an
Agreement of Resignation, Appointment and Acceptance effective May 5, 2005, providing for the replacement of The Bank of New York as an additional trustee under the Indenture with The Bank of New York Trust Company, N.A. 
 WHEREAS, the Company, J.P. Morgan Trust Company, N.A. (successor in interest to Bank One Trust Company, National Association) and The Bank of 

  

 1 

 
New York Trust Company, N.A. entered into that certain Second Supplemental Indenture dated June 23, 2006 (the “Second Supplemental
Indenture”), (i) creating and authorizing a series of Securities under the Base Indenture entitled “6.375% Senior Notes due 2016” (the “2016 Notes”) and (ii) appointing The Bank of New York Trust
Company, N.A. as an additional trustee pursuant to Section 901(6) of the Base Indenture with respect to the 2016 Notes. 
 WHEREAS, The
Bank of New York Trust Company, N.A. succeeded to the corporate trust business of J.P. Morgan Trust Company, N.A. effective October 1, 2006. 
 WHEREAS, the Trustee changed its name to The Bank of New York Mellon Trust Company, N.A. effective July 1, 2008. 
 WHEREAS,
Section 901(5) of the Base Indenture provides that a supplemental indenture may be entered into by the Company and the Trustee without the consent of any Holders to make provisions to establish the form or terms of Securities of any series as
permitted by Sections 201 and 301 of the Base Indenture. 
 WHEREAS, the Company has furnished the Trustee with (i) an Opinion of
Counsel stating that the execution of this Third Supplemental Indenture is authorized or permitted by the Base Indenture; (ii) an Officers’ Certificate stating that all conditions precedent under the Base Indenture for the execution of
this Third Supplemental Indenture have been satisfied; and (iii) a Secretary’s Certificate certifying the resolutions of the Board of Directors of the Company authorizing this Third Supplemental Indenture. 
 WHEREAS, for its lawful purposes, the Company desires to create and authorize a series of Securities under the Base Indenture entitled “9.25% Senior
Notes due 2019” (the “Notes”) in an initial aggregate principal amount of Three Hundred Million Dollars ($300,000,000) and, to provide the terms and conditions upon which the Notes are to be executed, registered, authenticated,
issued and delivered, the Company has duly authorized the execution and delivery of this Third Supplemental Indenture setting forth the terms of the Notes. 
 WHEREAS, this Third Supplemental Indenture shall amend the Base Indenture and supersede the First Supplemental Indenture and the Second Supplemental Indenture in their entirety but only with respect to the Notes; to
the extent the terms of the Base Indenture are inconsistent with this Third Supplemental Indenture, the terms of this Third Supplemental Indenture shall govern. 
 WHEREAS, all acts and things necessary to make the Notes, when executed by the Company and authenticated and delivered hereunder and duly 

  

 2 

 
issued by the Company, the valid, binding and legal obligations of the Company, and to make this Third Supplemental Indenture a valid, binding and legal
obligation of the Company, have been done and performed. 
 NOW, THEREFORE, in order to declare the terms and conditions upon which the Notes
are executed, registered, authenticated, issued and delivered, and in consideration of the premises, of the purchase and acceptance of such Notes by the Holders thereof, the Company covenants and agrees with the Trustee, for the equal and
proportionate benefit of the respective Holders from time to time of such Notes, as follows: 
 ARTICLE 1 
 DEFINITIONS 
 Section 1.01. Definitions. For all purposes of the Indenture, except as otherwise expressly provided or unless the context otherwise requires: 
 (i) the terms defined in this Article 1 have the meanings assigned to them in this Article and include the plural as well as the singular;

 (ii) capitalized terms not defined herein have the meanings given in the Base Indenture; 
 (iii) all other terms used herein that are defined in the Trust Indenture Act, either directly or by reference therein, have the meanings
assigned to them therein; and 
 (iv) the words “herein,” “hereof’ and “hereunder” and other
words of similar import refer to this Third Supplemental Indenture as a whole and not to any particular Article, Section or other subdivision. 
 “Agent Members” has the meaning specified in Section 2.05. 
 “Applicable Procedures” means,
with respect to any transfer or exchange of or for beneficial interest in a Global Note, the rules and procedures of the Depositary, Euroclear and Clearstream that apply to such transfer or exchange. 
 “Clearstream” means Clearstream Banking, société anonyme, Luxembourg (formerly Cedel Bank, société anonyme),
and any successor thereto. 
 “Comparable Treasury Issue” means the United States Treasury security selected by a Reference
Treasury Dealer as having an actual or interpolated maturity comparable to the remaining term of the Notes called for redemption, that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new
issues of corporate debt securities of comparable maturity to the remaining term of the Notes called for redemption. 
  

 3 

 “Comparable Treasury Price” means, with respect to any Redemption Date, the average, as
determined by the Company or such agent as may be appointed by the Company for this purpose, of the Reference Treasury Dealer Quotations for that Redemption Date. 
 “Depositary” means The Depository Trust Company until a successor Depositary shall have become such pursuant to the applicable provisions of the Indenture and thereafter “Depositary” shall
mean such successor Depositary. 
 “Euroclear” means the Euroclear System and any successor thereto. 
 “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended. 
 “Global Note” means a Note in global form registered in the Security Register in the name of a Depositary or a nominee thereof.

 “Physical Notes” means permanent certificated Notes in registered form issued in denominations of $2,000 and integral
multiples of $1,000 above that amount. 
 “Principal Amount” of a Note means the Principal Amount as set forth on the face
of the Note. 
 “Redemption Date” shall mean the date specified for redemption of the Notes in accordance with the terms of
the Notes and Section 3.01. 
 “Redemption Price” has the meaning specified in Section 3.01. 
 “Reference Treasury Dealer” means Wachovia Capital Markets, LLC, SunTrust Robinson Humphrey, Inc. and one other U.S. Government
securities dealer selected by the Company, and each of their respective successors. 
 “Reference Treasury Dealer
Quotations” means, on any Redemption Date, the average, as determined by the Company or such agent as may be appointed by the Company for this purpose, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as
a percentage of its principal amount) quoted in writing to the Company by each Reference Treasury Dealer at 3:30 p.m., New York City time, on the third Business Day preceding that Redemption Date. 
 “Remaining Scheduled Payments” means the remaining scheduled payments of principal of and interest on the Notes called for redemption
that would be due after the related Redemption Date but for that redemption; provided  

  

 4 

 
that if a Redemption Date is not an Interest Payment Date, the amount of the next succeeding scheduled interest payment on the Notes will be reduced by the
amount of interest accrued on the Notes to such Redemption Date. 
 “Treasury Rate” means, with respect to any Redemption
Date, the rate per year equal to the semi-annual equivalent yield to maturity (computed as of the third Business Day immediately preceding that Redemption Date) of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue
(expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for that Redemption Date. 
 ARTICLE 2 

THE NOTES 
 Section 2.01. Title and Terms. There is hereby created and authorized under the Base Indenture a series of Securities entitled “9.25% Senior Notes due 2019,” which shall be a series limited initially to $300,000,000
aggregate Principal Amount (except that the Company may, without the consent of Holders, reopen this series of Notes and issue additional Notes so as to increase the aggregate Principal Amount of Notes Outstanding in compliance with the procedures
set forth in the Base Indenture, so long as any such additional Notes have the same tenor and terms (including, without limitation, rights to receive accrued and unpaid interest as the Notes then Outstanding); provided that no such additional Notes
may be issued unless they are treated as part of the same “issue” as the Notes for U.S. federal income tax purposes; and further provided that the additional Notes have the same CUSIP number as the Notes). For all purposes of the
Indenture, the term “Notes” shall include the Notes initially issued on the date of original issuance of the Notes and any other Notes issued after such date under the Indenture. For purposes of the Indenture, all Notes shall vote together
and otherwise constitute a single series of Securities. 
 The Notes shall rank equally and pari passu with all other unsecured and
unsubordinated indebtedness of the Company. 
 Section 2.02. Forms of Notes. The Notes shall be substantially in the form set
forth in Exhibit A hereto with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by the Indenture, and with such letters, numbers or other marks of identification and such legends or
endorsements placed thereon as may be required to comply with the rules of any securities exchange or Depositary therefor, the Internal Revenue Code of 1986, as amended, and the regulations thereunder, or as may, consistently herewith, be determined
by the officers executing such Notes, as evidenced by their execution thereof. 
 The terms and provisions contained in the form of Notes
attached hereto as Exhibit A shall constitute, and are hereby expressly made, a part of this Third 

  

 5 

 
Supplemental Indenture and the Company and the Trustee, by their execution and delivery of this Third Supplemental Indenture, expressly agree to such terms
and provisions and to be bound thereby. 
 The Notes shall initially be issued in the form of a permanent Global Note in registered form. The
aggregate Principal Amount of the Global Note may from time to time be increased or decreased by adjustments made on the records of the Trustee, as custodian for the Depositary, as hereinafter provided. 
 Section 2.03. Denominations. The Notes shall be issuable only in registered form without coupons and in denominations of $2,000 and integral
multiples of $1,000 above that amount. 
 Section 2.04. Registration of Transfer and Exchange. The Company shall cause to be kept
at the Corporate Trust Office of the Trustee a register (the register maintained in such office and in any other office or agency designated pursuant to Section 1002 of the Base Indenture being herein sometimes collectively referred to as the
“Security Register”) in which, subject to such reasonable regulations as it may prescribe, the Company shall provide for the registration of Notes and of transfers of Notes. The Trustee is hereby appointed “Security
Registrar” (the “Security Registrar”) for the purpose of registering Notes and transfers of Notes as herein provided. 
 Upon surrender for registration of transfer of any Note at an office or agency of the Company designated pursuant to Section 1002 of the Base Indenture for such purpose, the Company shall execute, and the Trustee shall authenticate and
deliver, in the name of the designated transferee or transferees, one or more new Notes of any authorized denominations and of a like aggregate principal amount and tenor. 
 At the option of the Holder and subject to the other provisions of this Section 2.04 and Section 2.05 hereof and Section 309 of the Base
Indenture, Notes may be exchanged for other Notes of any authorized denominations and of a like aggregate principal amount and tenor, upon surrender of the Notes to be exchanged at such office or agency. Whenever any Notes are so surrendered for
exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Notes which the Holder making the exchange is entitled to receive. 
 All Notes issued upon any registration of transfer or exchange of Notes shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under the Indenture, as the Notes
surrendered upon such registration of transfer or exchange. 
 Every Note presented or surrendered for registration of transfer or for
exchange shall (if so required by the Company or the Trustee) be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Note Registrar duly executed, by the Holder thereof or his attorney
duly authorized in writing. 
  

 6 

 No service charge shall be made for any registration of transfer or exchange of Notes, but the Company
may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any registration of transfer or exchange of Notes, other than exchanges pursuant to Section 304 of the Base Indenture
not involving any transfer. 
 If the Company elects to redeem Notes, it shall not be required to (i) issue, register the transfer of or
exchange any Note during the period beginning at the opening of business 15 days before the day the Company mails the notice of redemption and ending at the close of business on the day such notice of redemption is mailed or (ii) register the
transfer or exchange of any Note after a notice of redemption has been given to Holders except, where such notice provides that such Note is to be redeemed only in part, the Company shall be required to exchange or register a transfer of the portion
thereof not to be redeemed. 
 Neither the Trustee nor any of its agents shall (i) have any duty to monitor compliance with or with
respect to any federal or state or other securities or tax laws or (ii) have any duty to obtain documentation relating to any transfers or exchanges other than as specifically required hereunder. 
 As used in this Section, the term “transfer” encompasses any sale, pledge, transfer or other disposition of any Note. 
 Section 2.05. Book-Entry Provisions for a Global Note. (a) The Global Note initially shall be registered in the name of the Depositary
or the nominee of such Depositary and be delivered to the Trustee as custodian for the Depositary. 
 Investors may hold their interests in
the Global Note directly through the Depositary, Euroclear or Clearstream, if they are members of or participants in such systems (“Agent Members”), or indirectly through organizations that are Agent Members in such systems. If
interests in the Global Note are held through Euroclear or Clearstream, Euroclear and Clearstream shall hold such interests in the Global Note through the Depositary on behalf of their Agent Members. 
 Agent Members of the Depositary, Euroclear or Clearstream shall have no rights under the Indenture with respect to any Global Note held on their behalf
by the Depositary, or the Trustee as its custodian, or under the Global Note, and the Depositary may be treated by the Company, the Trustee and any agent of the Company or the Trustee as the absolute owner of the Global Note for all purposes
whatsoever. Notwithstanding the foregoing, nothing herein shall prevent the Company, the Trustee or any agent of the Company or the Trustee from giving effect to any written certification, proxy or other authorization furnished by the 

  

 7 

 
Depositary or impair, as between the Depositary and its Agent Members, the operation of customary practices governing the exercise of the rights of any
Holder. 
 (b) Transfers of the Global Note shall be limited to transfers in whole, but not in part, to the Depositary, its successors or
their respective nominees. Interests of beneficial owners in a Global Note may be transferred or exchanged, in whole or in part, for Physical Notes in accordance with the rules and procedures of the Depositary and the provisions of Section 309
of the Base Indenture. In addition, Physical Notes shall be transferred to all beneficial owners in exchange for their beneficial interests in the Global Note if (a) such Depositary has notified the Company (or the Company becomes aware) that
the Depositary (i) is unwilling or unable to continue as Depositary for such Global Note or (ii) has ceased to be a clearing agency registered under the Exchange Act when the Depositary is required to be so registered to act as such
Depositary and, in either such case, no successor Depositary shall have been appointed within 90 days of such notification or of the Company becoming aware of such event; (b) there shall have occurred and be continuing an Event of Default with
respect to such Global Note; or (c) the Company, at its option, elects to terminate the book-entry system through the Depositary. 
 (c)
In connection with any transfer or exchange of a portion of the beneficial interest in the Global Note to beneficial owners pursuant to paragraph (b) above, the Security Registrar shall (if one or more Physical Notes are to be issued) reflect
on its books and records the date and a decrease in the Principal Amount of the Global Note in an amount equal to the Principal Amount of the beneficial interest in the Global Note to be transferred, and the Company shall execute, and the Trustee
shall authenticate and deliver, one or more Physical Notes of like tenor and amount. 
 (d) In connection with the transfer of the entire
Global Note to beneficial owners pursuant to paragraph (b) above, the Global Note shall be deemed to be surrendered to the Trustee for cancellation, and the Company shall execute, and the Trustee shall authenticate and deliver, to each
beneficial owner identified by the Depositary in exchange for its beneficial interest in the Global Note, an equal aggregate Principal Amount of Physical Notes of authorized denominations and the same tenor. 
 (e) The Holder of the Global Note may grant proxies and otherwise authorize any Person, including Agent Members and Persons that may hold interests
through Agent Members, to take any action which a Holder is entitled to take under the Indenture or the Notes. 
 (f) None of the Company,
the Trustee, any Paying Agent or any Security Registrar will have any responsibility or liability for any aspect of Depositary records relating to, or payments made on account of, beneficial 

  

 8 

 
ownership interests in a Global Note or for maintaining, supervising or reviewing any Depositary records relating to such beneficial ownership interests, or
for transfers of beneficial interests in the Notes or any transactions between the Depositary and beneficial owners. 
 Section 2.05.
Euroclear and Clearstream Procedures Applicable. The provisions of the “Operating Procedures of the Euroclear System” and “Terms and Conditions Governing Use of Euroclear” and the “General Terms and Conditions”
and “Customer Handbook” of Clearstream shall be applicable to transfers of beneficial interests in any Global Note held by Agent Members through Euroclear and Clearstream. 
 ARTICLE 3 
 REDEMPTION 
 Section 3.01. Optional Redemption of Notes by the Company. The Notes will not be redeemable at the option of any Holder thereof, upon the
occurrence of any particular event or otherwise. The Notes will be redeemable, in whole or in part, at the option of the Company, at any time or from time to time, at a Redemption Price equal to the greater of (a) 100% of the principal amount
of the Notes to be redeemed and (b) the sum of the present values of the Remaining Scheduled Payments on such Notes discounted to the Redemption Date, on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at a rate
equal to the sum of the applicable Treasury Rate plus 75 basis points (the “Redemption Price”). The Redemption Price will be provided to the Trustee by the Company. 
 The Company shall give notice to the Trustee of its election to redeem Notes by a Company Order, at least 30 days but not more than 60 days before the
Redemption Date (unless a shorter notice shall be satisfactory to the Trustee). 
 Section 3.02. Selection of Notes to be Redeemed.
If less than all the Notes are to be redeemed, the Trustee shall select the Notes to be redeemed pro rata or by lot or by any other method the Trustee considers fair and appropriate (so long as such method is not prohibited by the rules of any
stock exchange on which the Notes are then listed). The Trustee shall make the selection within 7 days from its receipt of the notice from the Company delivered pursuant to the second paragraph of Section 3.01 from Outstanding Notes not
previously called for redemption. 
 Notes, or portions thereof selected by the Trustee for redemption, shall be in denominations of $2,000
and integral multiples of $1,000 above that amount. Provisions of the Indenture that apply to Notes called for redemption in whole also apply to Notes called for redemption in part. The Trustee shall notify the Company promptly of the Notes or
portions of Notes to be redeemed. 
  

 9 

 Section 3.03. Notice of Redemption. At least 30 days but not more than 60 days before a
Redemption Date, the Company shall mail a notice of redemption by first-class mail, postage prepaid, to each Holder of Notes to be redeemed. The notice shall identify the Notes to be redeemed and shall state: 
 (i) the aggregate principal amount of Notes to be redeemed; 
 (ii) the Redemption Date; 
 (iii) the amount of interest accrued to the Redemption Date on the Notes to be redeemed; 
 (iv) that on and after the Redemption Date, interest on the Notes to be redeemed, or on the portion thereof to be redeemed, will cease to accrue; 
 (v) the name and address of the Paying Agent; 
 (vi) that Notes called for redemption must be
surrendered to the Paying Agent for cancellation to collect the Redemption Price; 
 (vii) if fewer than all the outstanding
Notes are to be redeemed, the certificate number (if such Notes are held other than in global form) and principal amounts of the particular Notes to be redeemed; and 
 (viii) the CUSIP number of the Notes being redeemed. 
 At the Company’s written request delivered at least 30 days prior to the date such notice is to be given (unless a shorter time period shall be acceptable to the Trustee), the Trustee shall give the notice of
redemption in the Company’s name and at the Company’s expense. 
 Section 3.04. Effect of Notice of Redemption. Once
notice of redemption is given, Notes called for redemption become due and payable on the Redemption Date and at the Redemption Price stated in the notice. Upon surrender to the Paying Agent, such Notes shall be paid at the Redemption Price stated in
the notice. Unless the Company Defaults on the payment of the Redemption Price, interest will cease to accrue on the Notes or portions thereof called for redemption. 
 Section 3.05. Deposit of Redemption Price. Prior to 11:00 a.m. (New York City time) on a Redemption Date, the Company shall deposit with the Paying Agent (or if the Company or a Subsidiary or an Affiliate
of either of them is the Paying Agent, shall segregate and hold in trust) money sufficient to pay the Redemption Price of all Notes to be redeemed on that date other than Notes or portions of Notes called for redemption which on or prior thereto
have been delivered by the Company to the Trustee for cancellation. 
  

 10 

 Section 3.06. Notes Redeemed in Part. Upon surrender of a Note that is redeemed in part, the
Company shall execute and the Trustee shall authenticate and deliver to the Holder a new Note in an authorized denomination equal in principal amount to the unredeemed portion of the Note surrendered. 
 ARTICLE 4 
 REMEDIES 

Section 4.01. Events of Default. In addition to the Events of Default set forth in Article Five of the Base Indenture, the following shall
be an Event of Default with respect to the Notes: 
 (a) failure to pay principal or premium, if any, on any Note called for redemption on a
Redemption Date. 
 ARTICLE 5 
 COVENANTS 
 Section 5.01. Definition of Designated Subsidiaries. For purposes of Article Ten of the Base
Indenture, “Designated Subsidiary” means each of Liberty National Life Insurance Company, United American Insurance Company, Globe Life And Accident Insurance Company, United Investors Life Insurance Company and American Income Life
Insurance Company, so long as it remains a Subsidiary, or any Subsidiary that is a successor of such Designated Subsidiary, as well as any other Subsidiary of the Company that would be deemed a Significant Subsidiary as such term is defined in
Regulation S-X promulgated by the Commission. 
 ARTICLE 6 
 MISCELLANEOUS PROVISIONS 
 Section 6.01. Trust Indenture Act. This
Third Supplemental Indenture is hereby made subject to, and shall be governed by, the provisions of the Trust Indenture Act required to be part of and to govern indentures qualified under the Trust Indenture Act. If any provision hereof limits,
qualifies or conflicts with another provision hereof which is required to be included in an indenture qualified under the Trust Indenture Act, such required provision shall control. 
 Section 6.02. Effect of Headings and Table of Contents. The Article and Section headings herein are for convenience only and shall not affect
the construction hereof, and all Article and Section references are to Articles and Sections, respectively, of this Third Supplemental Indenture unless otherwise expressly stated. 
  

 11 

 Section 6.03. Successors and Assigns. All covenants and agreements in this Third Supplemental
Indenture by the Company shall bind its successors and assigns, whether so expressed or not. 
 Section 6.04. Severability
Clause. In case any provision in this Third Supplemental Indenture or in the Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired
thereby. 
 Section 6.05. Benefits of Third Supplemental Indenture. Nothing in this Third Supplemental Indenture or in the Notes,
express or implied, shall give to any Person, other than the parties hereto and their respective successors hereunder and the Holders of Notes, any benefit or any legal or equitable right, remedy or claim under this Third Supplemental Indenture.

 Section 6.06. Governing Law. This Third Supplemental Indenture and the Notes shall be governed by and construed in accordance
with the laws of the State of New York, without regard to the conflicts of laws rules of such state. 
 Section 6.07.
Counterparts. This Third Supplemental Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.

 Section 6.08. Not Responsible for Recitals or Use of Proceeds from the Issuance of the Notes. The recitals contained herein
(excluding the fifth, sixth, seventh and eighth recitals) shall be taken as the statements of the Company, and the Trustee assumes no responsibility for their correctness. Except for the Trustee's certificate of authentication on the Notes, the
Trustee makes no representations as to the validity or sufficiency of this Third Supplemental Indenture or of the Notes. The Trustee shall not be accountable for the use or application by the Company of the proceeds from the issuance of the Notes.

  

 12 

 IN WITNESS WHEREOF, the Company has caused this Third Supplemental Indenture to be signed and delivered,
and the Trustee has caused this Third Supplemental Indenture to be signed and delivered, all as of the day and year first written above. 
  

			
	TORCHMARK CORPORATION
		
	By:	 	  

	Name:	 	Danny H. Almond
	Title:	 	Vice President and Chief Accounting Officer
	
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee
		
	By:	 	  

	Name:	 	Stuart E. Statham
	Title:	 	Vice President

 [Signature Page to Third Supplemental Indenture] 
  

 13 

 EXHIBIT A 
 [FORM OF FACE OF NOTE] 
 THIS NOTE IS A GLOBAL NOTE WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND
IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF. THIS NOTE MAY NOT BE EXCHANGED IN WHOLE OR IN PART FOR A NOTE REGISTERED, AND NO TRANSFER OF THIS NOTE IN WHOLE OR IN PART MAY BE REGISTERED, IN THE NAME OF ANY PERSON OTHER THAN SUCH
DEPOSITARY OR A NOMINEE THEREOF, EXCEPT IN THE LIMITED CIRCUMSTANCES DESCRIBED IN THE INDENTURE. 
 UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED
REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (“DTC”), A NEW YORK CORPORATION, TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR
IN SUCH OTHER NAME AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC (AND ANY PAYMENT IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF DTC), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR
VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL IN AS MUCH AS THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
 TORCHMARK CORPORATION 
 9.25% Senior Notes due 2019 
  

			
	No.	 	CUSIP NO. 891027 AP9

 TORCHMARK CORPORATION, a corporation duly organized and existing under the laws of the State of
Delaware (herein called the “Company,” which term includes any successor corporation under the Indenture hereinafter referred to on the reverse hereof), for value received, promises to pay to CEDE & CO., or its registered
assigns, the principal sum of THREE HUNDRED MILLION DOLLARS ($300,000,000) or such other amount as indicated on the Schedule of Increases and Decreases attached hereto on June 15, 2019. 
  

 A-1 

 Interest Rate: 9.25% per year 
 Interest Payment Dates: June 15 and December 15 of each year, commencing December 15, 2009 
 Record Dates: June 1 and December 1 
 Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which will for all purposes have the same effect as if set forth at this place. 
  

 A-2 

 IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed under its corporate seal.

  

			
	TORCHMARK CORPORATION
		
	By:	 	  

	Name:	 	
	Title:	 	

  

			
	Attest:
		
	By:	 	  

	Name:	 	
	Title:	 	

  

 A-3 

 This is one of the 9.25% Senior Notes due 2019 referred to in the within-mentioned Indenture. 

Dated: June 30, 2009 
  

			
	 THE BANK OF NEW YORK MELLON
 TRUST COMPANY,
N.A., as Trustee

		
	By:	 	  

		 	Authorized Signatory

  

 A-4 

 [FORM OF REVERSE OF NOTE] 
 TORCHMARK CORPORATION 
 9.25% Senior Notes due 2019 
 Indenture; Defined Terms. This Note is one of the 9.25% Senior Notes Due 2019 of the Company issued under an Indenture dated February 1, 1987
(the “Base Indenture”), between the Company and J.P. Morgan Trust Company, National Association, as supplemented by the Third Supplemental Indenture dated June 30, 2009 (the “Third Supplemental Indenture” and,
together with the Base Indenture, the “Indenture”) between the Company and The Bank of New York Mellon Trust Company, N.A. (ultimate successor-in-interest to Morgan Guaranty Trust Company of New York, the
“Trustee”). 
 Unless otherwise defined herein, capitalized terms herein are used as defined in the Indenture. The terms of
the Notes include those stated in the Indenture and those made part thereof by reference to the Trust Indenture Act of 1939 (15 U.S.C. Sections 77aaa-77bbbb) (the “Trust Indenture Act”), as in effect on the date hereof.
Notwithstanding anything to the contrary herein, the Notes are subject to all such terms, and holders of Notes are referred to the Indenture and the Trust Indenture Act for a statement of such terms. To the extent the terms of the Indenture, the
Third Supplemental Indenture and this Note are inconsistent, the terms of the Third Supplemental Indenture shall govern. 
 Interest.
The Company promises to pay cash interest on the Principal Amount of the Notes at the rate per year described above. Interest on the Notes will accrue from June 30, 2009, or from the most recent Interest Payment Date to which interest has been
paid or duly provided for, to but excluding the next Interest Payment Date. The Company will pay interest semi-annually in arrears on each Interest Payment Date, commencing December 15, 2009, to the Person in whose name the Notes are registered
at the close of business on the immediately preceding Record Date. Interest payable upon redemption will be paid to the Person to whom principal is paid. Interest will be computed on the basis of a 360-day year of twelve 30-day months. 

If an Interest Payment Date, the Stated Maturity or a Redemption Date for the Notes falls on a day that is not a Business Day, the interest payment
shall be postponed to the next succeeding Business Day, and no interest on such payment shall accrue for the period from and after such Interest Payment Date, the Stated Maturity or a Redemption Date. 
 If a Holder of at least $2,000,000 principal amount of Notes has given wire transfer instructions to the Company no later than 15 days immediately
preceding the relevant due date for payment (or such date as the Trustee may 

  

 A-5 

 
accept in its discretion), the Company will pay, or cause to be paid by the Paying Agent, all principal and interest on the Holder’s Notes in accordance
with those instructions. Other payments on the Notes will be made to the Holders at their address set forth in the Security Register. 
 Redemption of Notes at the Option of the Company. The Notes are redeemable, in whole or in part, at the option of the Company, at any time or from time to time, at a redemption price equal to the greater of (a) 100% of the
principal amount to be redeemed and (b) the sum of the present values of the Remaining Scheduled Payments on such Notes discounted to the Redemption Date, on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at a
rate equal to the sum of the applicable Treasury Rate plus 75 basis points (the “Redemption Price”) upon delivery of the Notes to the Paying Agent by the Holder as set forth in the Indenture. The Redemption Price will be paid in
cash. 
 Notice of any redemption will be mailed at least 30 days but not more than 60 days before the Redemption Date to each
Holder of the Notes to be redeemed. Unless the Company defaults in payment of the Redemption Price, on and after the Redemption Date, interest will cease to accrue on the Notes or portions thereof called for redemption. If less than all of the Notes
are to be redeemed, the Notes to be redeemed shall be selected pro rata or by lot or by any other method the Trustee considers fair and appropriate. 
 The Notes are not subject to any sinking fund. 
 Paying Agent. Initially, The Bank of New York Mellon
Trust Company, N.A. will act as Paying Agent. The Company may change any paying agent without notice to the Holders. 
 Covenants. The
Indenture contains certain restrictive covenants and provisions for defeasance at any time of (a) the entire indebtedness evidenced by the Notes and (b) such restrictive covenants, in each case upon compliance by the Company with certain
conditions set forth therein, which covenants and provisions apply to the Notes. 
 Events of Default. If an Event of Default with
respect to the Notes shall occur and be continuing, the principal of the Notes may be declared due and payable in the manner and with the effect provided in the Indenture. 
 Amendment; Supplement; Waiver. The Indenture permits, with certain exceptions as therein provided, the amendment thereof and
the modification of the rights and obligations of the Company and the rights of the Holders of the Notes at any time by the Company and the Trustee with the consent of the Holders of 66 2/3% in aggregate principal amount of Notes at the time Outstanding. The Indenture also contains provisions permitting the Holders of specified percentages 

  

 A-6 

 
in aggregate principal amount of Notes at the time Outstanding, on behalf of the Holders of the Notes, to waive compliance by the Company with certain
provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of
any Note issued upon the registration of transfer hereof or in exchange thereof of in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. 
 No reference herein to the Indenture and no provision of the Notes or the Indenture shall alter or impair the obligation of the Company, which is
absolute and unconditional, to pay the principal of and interest on the Notes at the times, place and rate, and in the coin or currency, herein prescribed. 
 Persons Deemed Owners. The registered Holder of this Note may be treated as the owner of this Note for all purposes. 
 Denominations; Transfer and Exchange. The Notes are in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 above that amount. A Holder may transfer or exchange Notes in
accordance with the Indenture. The Security Registrar may require a Holder, among other things, to furnish appropriate endorsements and transfer documents and to pay to it any taxes and required by law or permitted by the Indenture. The Registrar
shall not be required to exchange or register a transfer of any Note for a period of 15 days immediately preceding a Redemption Date. 
 Authentication. This Note shall not be valid until the Trustee signs the certificate of authentication on the front hereof. 
 Governing Law This Note shall be governed by and construed in accordance with the laws of the State of New York, without regard to the conflicts of laws rules of such state. 
  

 A-7 

 FORM OF ASSIGNMENT 
  

			
	 For value received,
	  	 
	hereby assigns or transfers unto

  

					
		  	 	  	
		  	(Print or type assignee’s name, address and zip code)	  	
			
		  	 	  	
		  	(Insert assignee’s soc. sec. or tax I.D. No.)	  	

 The within Note, and hereby irrevocably constitutes and appoints
                                         
                            attorney to transfer said Note on the books of the Company, with full power of
substitution in the premises. 
  

			
	Dated:	 	  

  

	
	  

	
	  

	Signature(s)
	
	Signature(s) must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar, which requirements include membership or participation in the
Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in accordance with the
Securities Exchange Act of 1934, as amended.
	
	  

	Signature Guarantee

 NOTICE: The signature on this Assignment must correspond with the name as written upon the face of the Note
in every particular without alteration or enlargement or any change whatever. 
  

 A-8 

 Schedule I 
 [Include Schedule I only for a Global Note] 
 SCHEDULE OF INCREASES OR DECREASES 
 The following increases or decreases in the principal amount of this Global Note have been made: 
  

									
	 Exchange
	  	 Amount of
decrease in
Principal Amount
of this Global Note
	  	 Amount of increase
in Principal
Amount of this
Global
Note
	  	 Principal Amount
of this Global Note
following such
increase or
decrease
	  	 Signature of
authorized
signatory of
TrusteeSecurities Subscription & Purchase Agreement bet. eDiets.com and Mr. Richardson

 Exhibit 10.1 
 SECURITIES SUBSCRIPTION AND PURCHASE AGREEMENT 
 eDiets.com, Inc. 
 1000 Corporate Drive Suite 600 
 Fort
Lauderdale FL 33334 
 The undersigned (the “Investor”) hereby confirms his agreement with you as follows: 
 1. This Securities Subscription and Purchase Agreement (this “Agreement”) is made as of June 23, 2009, between eDiets.com, Inc., a Delaware
corporation (the “Company”), and the Investors. 
 2. Pursuant to this Agreement and subject to its terms and conditions, the
Investor hereby subscribes for and will purchase from the Company and the Company will issue and sell to the Investor, in a private placement, the following securities (the “Securities”) for an aggregate purchase price of $300,000
(the “Purchase Price”): 
 (a) 300,000 shares (the “Shares”) of common stock of the Company, $0.001
par value per share, at a purchase price of $1.00 per Share, and 
 (b) a warrant (the “Warrant”) in the form of
Exhibit A to this Agreement and hereby incorporated by reference to purchase up to a number of shares equal to 45% of the Shares, which shall be exercisable on or after the Original Issue Date (as defined in the Warrant), have a term of
exercise equal to ten (10) years and have a strike price of $1.20 per share. 
 3. The Company and the Investor agree to enter into a
registration rights agreement (the “Registration Rights Agreement”) in the form of Exhibit B to this Agreement, concurrently with the execution of this Agreement. (the Agreement and the Registration Rights Agreement
collectively the “Agreements”). 
 4. Unless otherwise agreed between the Company and the Investor, the closing of the transactions
contemplated by this Agreement shall take place at the offices of the Company on or before July 15, 2009 (the “Closing”). 
 5.
The Company’s obligation to issue and sell the Securities shall be subject to the following conditions, any one or more of which may be waived by the Company: 
 (a) prior receipt by the Company of an executed copy of this Agreement; 
 (b) the execution
and delivery by the Investor of the Registration Rights Agreement; 
 (c) the accuracy in all material respects when made and at the
Closing of the representations and warranties made by the Investor in this Agreement and the fulfillment of the obligations of the Investor to be fulfilled by the Investor under this Agreement on or prior to the Closing in all material respects;

 (d) receipt of the Purchase Price; and 
  

 1 

 (e) the execution and delivery by the Investor of a cross receipt evidencing receipt of the Shares
and the Warrant. 
 6. The Investor’s obligation to purchase the Securities shall be subject to the following conditions, any one or more of
which may be waived by the Investor: 
 (a) prior receipt by the Company of an executed copy of this Agreement; 
 (b) the execution and delivery by the Company of the Registration Rights Agreement; 
 (c) the accuracy in all material respects when made and at the Closing of the representations and warranties made by the Company in this Agreement
and the fulfillment of the obligations of the Company to be fulfilled by it under this Agreement on or prior to the Initial Closing in all material respects; and 
 (d) the execution and delivery by the Company of a cross receipt evidencing receipt of the Purchase Price. 
 7.
Certificates representing the Shares and Warrants purchased by the Investor, respectively, will be registered in the Investor’s name and address as set forth below. 
 8. The Investor represents and warrants to, and covenants with, the Company as follows: 
 (a)
the Investor was at the time it was offered the Securities, is as of the date hereof and as of the Closing and will be on each date it exercises the Warrant an “accredited investor” as such term is defined in Rule 501 of Regulation D
promulgated pursuant to the Securities Act of 1933, as amended, is knowledgeable, sophisticated and experienced in making, and is qualified to make decisions with respect to, investments in securities presenting an investment decision similar to
that involved in the purchase of the Securities, and has requested, received, reviewed and considered all information the Investor deemed relevant in making an informed decision to purchase the Securities and is able to bear the economic risk of an
investment in the Securities and, at the present time, is able to afford a complete loss of such investment; 
 (b) the Investor
understands that the Securities are “restricted securities” and have not been registered under the Securities Act, or registered or qualified under any state securities law, in reliance on specific exemptions therefrom, which exemptions
may depend upon, among other things, the representations made by the Investor in this Agreement; the Investor is acquiring the Securities in the ordinary course of business and for the Investor’s own account for investment only, has no present
intention of distributing any of such Securities and has no arrangement or understanding with any other persons regarding the distribution of such Securities; and 
 (c) the Investor will not, directly or indirectly, offer, sell, pledge, transfer or otherwise dispose of (or solicit any offers to buy, purchase or otherwise acquire or take a pledge of) any of the Securities
except in compliance with the Securities Act, applicable state securities laws and the respective rules and regulations promulgated thereunder. 
 9.
The Company represents and warrants to, and covenants with, the Investor as follows: 
 (a) The Company is duly incorporated and
validly existing in good standing under the laws of the State of Delaware, has full power and authority to own, operate and occupy its properties and to conduct its business as presently conducted and is registered or qualified to do business and in
good standing in each jurisdiction in which it owns or leases property or transacts business and where the failure to be so qualified would have a material adverse effect upon the Company and its subsidiaries as a whole or the business, financial
condition, prospects, properties, operations or assets of the Company and its subsidiaries as a whole or the Company’s ability to perform its obligations under this Agreement in all material respects, and no proceeding has been instituted in
any such jurisdiction revoking, limiting or curtailing, or seeking to revoke, limit or curtail, such power and authority or qualification; 
  

 2 

 (b) The Company has all requisite power and authority to execute, deliver and perform its
obligations under this Agreement; the execution and delivery of this Agreement, and the consummation by the Company of the transactions contemplated hereby, have been duly authorized by all necessary corporate action and no further action on the
part of the Company or the Board or shareholders is required; and 
 (c) The Securities to be sold pursuant to this Agreement have
been duly authorized, and when issued and paid for in accordance with the terms of this Agreement, will be duly and validly issued, fully paid and nonassessable, subject to no lien, claim or encumbrance (except for any such lien, claim or
encumbrance created, directly or indirectly, by the Investor). 
 10. Notwithstanding any investigation made by any party to this Agreement, all
covenants, agreements, representations and warranties made by the Company and the Investor herein shall survive the execution of this Agreement, the delivery to the Investor of the Securities being purchased and the payment therefor, and a
party’s reliance on such representations and warranties shall not be affected by any investigation made by such party or any information developed thereby. 
 11. All notices, requests, consents and other communications hereunder shall be in writing, shall be delivered (A) if within the United States, by first-class registered or certified airmail, or nationally recognized overnight
express courier, postage prepaid, or by facsimile, or (B) if from outside the United States, by FedEx (or comparable service) or facsimile, and shall be deemed given: (i) if delivered by first-class registered or certified mail domestic,
upon the business day received, (ii) if delivered by nationally recognized overnight carrier, one (1) business day after timely delivery to such carrier, (iii) if delivered by FedEx (or comparable service), two (2) business days
after timely delivery to such carrier, or (iv) if delivered by facsimile, upon electric confirmation of receipt and shall be addressed as follows, or to such other address or addresses as may have been furnished in writing by a party to another
party pursuant to this paragraph: 
 (a) if to the Company, to: 
 eDiets.com, Inc. 
 1000 Corporate Drive Suite 600 
 Fort Lauderdale FL 33334 
 Attention: Chief Executive Officer 
 Facsimile: (954) 938 0031 
  

 3 

 (b) if to the Investor, c/o Prides Capital Partners, LLC, 200 High Street, Suite 700, Boston, MA
02110, Facsimile: (617) 778-9299. 
 12. This Agreement may not be modified or amended except pursuant to an instrument in writing signed by the
Company and the Investor. Any waiver of a provision of this Agreement must be in writing and executed by the party against whom enforcement of such waiver is sought. 
 13. The headings of the various sections of this Agreement have been inserted for convenience of reference only and shall not be deemed to be part of this Agreement. 
 14. This Agreement sets forth the entire agreement and understanding of the parties relating to the subject matter hereof and supersedes all prior and
contemporaneous agreements, negotiations and understandings between the parties, both oral and written relating to the subject matter hereof. If any provision contained in this Agreement is determined to be invalid, illegal or unenforceable in any
respect, the validity, legality and enforceability of the remaining provisions contained herein shall not in any way be affected or impaired thereby. 
 15. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without giving effect to the principles of conflicts of law. 
 16. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. No party may assign this Agreement or
any rights or obligations hereunder without the prior written consent of the other. 
 17. This Agreement may be executed in two or more counterparts,
each of which shall constitute an original, but all of which, when taken together, shall constitute but one instrument, and shall become effective when one or more counterparts have been signed by each party hereto and delivered to the other
parties. In the event that any signature is delivered by fax or electronic mail, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if
such signature were an original. 
 [Remainder of Page Intentionally Left Blank.] 
  

 4 

 Please confirm that the foregoing correctly sets forth the agreement between us by signing below.

  

	
	Dated as of: June 23, 2009
	
	 /s/ Kevin A. Richardson II

	Investor: KEVIN A. RICHARDSON II

  

			
	AGREED AND ACCEPTED:
	
	eDiets.com, Inc.
		
	By:	 	 /s/ Thomas Hoyer

	Name:	 	Thomas Hoyer
	Title:	 	Chief Financial Officer

  

			
	Exhibit A:	  	Form of Warrant
		
	Exhibit B:	  	Form of Registration Rights Agreement

 [SECURITIES SUBSCRIPTION AND PURCHASE AGREEMENT SIGNATURE PAGE] 
  

 5 

 THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAW. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR UNLESS SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND
PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT OR THE ISSUER HAS RECEIVED AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY ACCEPTABLE TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER THE ACT OR APPLICABLE STATE SECURITIES LAWS. THESE
SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT SECURED BY SUCH SECURITIES. 
 eDiets.com, Inc. 
 Warrant for the Purchase of Shares of 
 Common Stock 
  

			
	                                 Shares	  	                         ,
20    

 FOR VALUE RECEIVED, eDiets.com, Inc., a Delaware corporation (the “Company”), hereby
certifies that                                  or his assigns, is entitled to purchase
from the Company, at any time or from time to time commencing on the date hereof (the “Initial Exercise Date”) and expiring at 5:00 P.M., New York City time, on the ten (10) year anniversary of the Original Issue Date (the
“Expiration Date”)                                 
(                        ) fully paid and non-assessable shares of Common Stock, par value $.001 per share, of the Company (the
“Warrant Shares”) for a per share exercise price of $1.20 (the “Per Share Warrant Price”). The Per Share Warrant Price is subject to adjustment as hereinafter provided. Capitalized terms used and not otherwise defined in this
Warrant shall have the meanings specified in Section 8, unless the context otherwise requires. 
 1. Exercise of Warrant.

 (a) This Warrant may be exercised, in whole at any time or in part from time to time, commencing on the Initial Exercise Date and expiring
at 5:00 P.M., New York City time, on the Expiration Date (with the Exercise Notice at the end of this Warrant duly executed) at the address set forth in Section 10 hereof, together with payment of the Per Share Warrant Price multiplied by the
number of Warrant Shares to which such exercise relates made by delivery to the Company of one or more types of Permitted Consideration. 
 (b) If this Warrant is exercised in part, the Company will deliver to the Holder within three Trading Days of the date such Holder delivers to the Company this Warrant and an Exercise Notice, together with the payment of the aggregate Per
Share Warrant Price for such exercise, a new Warrant covering the Warrant Shares that have not been exercised. By the expiration of the third Trading Day following the Holder’s delivery of a Warrant, together with an Exercise Notice and the
payment of the aggregate Per Share Warrant Price for such exercise, 

 
the Company will (i) issue a certificate or certificates in the name of the Holder for the largest number of whole shares of the Common Stock to which
the Holder shall be entitled and, if this Warrant is exercised in whole, in lieu of any fractional share of the Common Stock to which the Holder shall be entitled, pay to the Holder cash in an amount equal to the fair value of such fractional share
(determined by reference to the closing sales price of the Common Stock on the date of the Exercise Notice), and (ii) deliver the other securities and properties receivable upon the exercise of this Warrant, or the proportionate part thereof if
this Warrant is exercised in part, pursuant to the provisions of this Warrant. 
 (c) If, by the third Trading Day after the date that the
Holder delivers an Exercise Notice, together with the payment of the aggregate Per Share Warrant Price for such exercise, the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 1(b), then
the Holder will have the right to rescind such exercise. 
 (d) If, by the third Trading Day after the date that the Holder delivers an
Exercise Notice, together with the payment of the aggregate Per Share Warrant Price for such exercise, the Company fails to deliver the required number of Warrant Shares in the manner required pursuant to Section 1(b), and if after such third
Trading Day and prior to the receipt of such Warrant Shares, the Holder purchases (in an open market transaction or otherwise) shares of Common Stock to deliver in satisfaction of a sale by the Holder of the Warrant Shares which the Holder
anticipated receiving upon such exercise (a “Buy-In”), then the Company shall (1) pay in cash to the Holder the amount by which (x) the Holder’s total purchase price (including brokerage commissions, if any) for the shares
of Common Stock so purchased exceeds (y) the amount obtained by multiplying (A) the number of Warrant Shares that the Company was required to deliver to the Holder in connection with the exercise at issue by (B) the closing bid price
of the Common Stock at the time of the obligation giving rise to such purchase obligation and (2) at the option of the Holder, either reinstate the portion of the Warrant and equivalent number of Warrant Shares for which such exercise was not
honored or deliver to the Holder the number of shares of Common Stock that would have been issued had the Company timely complied with its exercise and delivery obligations hereunder. The Holder shall provide the Company written notice indicating
the amounts payable to the Holder in respect of the Buy-In. 
 (e) If, after the Required Effective Date (as defined in the Registration
Rights Agreement) the Warrant Shares to be issued are not registered and available for resale by the Holder pursuant to a registration statement in accordance with the Registration Rights Agreement, then notwithstanding anything contained herein to
the contrary, the Holder may, at its election exercised in its sole discretion, exercise a portion of this Warrant with respect to an aggregate total of twenty-five percent (25%) of the total Warrant Shares and, in lieu of making a cash payment
of Permitted Consideration, elect instead to receive upon such exercise the “Net Number” of shares of Common Stock determined according to the following formula: 
  

					
	Net Number	 	=	 	(A x B) – (A x C)
		 		 	            B

  

 2 

 For purposes of the foregoing formula: 
 A=the total number of Warrant Shares with respect to which this Warrant is then being exercised. 
 B=the average of the closing sales prices for the five Trading Days immediately prior to (but not including) the day that the Holder delivers the
Exercise Notice at issue. 
 C=the Per Share Warrant Price. 
 2. Company’s Option to Change Expiration Date. 
 Notwithstanding anything herein to the contrary,
in the event that (i) the closing sales price per share of Common Stock is in excess of 150% of the Per Share Warrant Price (as may be adjusted pursuant to Section 3) for thirty (30) consecutive Trading Days, (ii) the Warrant
Shares are either registered for resale pursuant to an effective registration statement naming the Holder as a selling stockholder thereunder (and the prospectus thereunder is available for use by the Holder as to all then available Warrant Shares)
or freely transferable without volume restrictions pursuant to Rule 144(k) promulgated under the Securities Act, as determined by counsel to the Company pursuant to a written opinion letter addressed and in form and substance reasonably acceptable
to the Holder and the transfer agent for the Common Stock, during the entire sixty (60) Trading Day period referenced in (i) above through the expiration of the Call Date as set forth in the Company’s notice pursuant to this Section
(the “Call Condition Period”), and (iii) the Company shall have complied in all material respects with its obligations under this Warrant and the Common Stock shall at all times be listed on the AMEX, New York Stock Exchange, the
Nasdaq National Market, the Nasdaq Capital Market or the OTC Bulletin Board, then, subject to the conditions set forth in this Section, the Company may, in its sole discretion, elect to change the Expiration Date for the respective Warrant to 5:00
P.M., New York City time on the date that is thirty (30) days after written notice thereof (a “Call Notice”) is received by the Holder (the “Call Date”) at the address last shown on the records of the Company for the Holder
or given by the Holder to the Company for the purpose of notice; provided, that the conditions to giving such notice must be in effect at all times during the Call Condition Period or any such notice shall be null and void. Notwithstanding anything
herein to the contrary, if the Company changes the Expiration Date pursuant to this Section 2, the Holder may, at its election exercised in its sole discretion, exercise a portion of this Warrant with respect to an aggregate total (including
any exercises made under Section 1(e)) of twenty-five percent (25%) of the total Warrant Shares and, in lieu of making a cash payment of Permitted Consideration, elect instead to receive upon such exercise the “Net Number” of
shares of Common Stock determined according to the formula set forth in Section 1(e). 
 3. Certain Adjustments. The Per Share
Warrant Price and number of Warrant Shares issuable upon exercise of this Warrant are subject to adjustment from time to time as set forth in this Section 3. 
 (a) If the Company, at any time while this Warrant is outstanding, (i) pays a stock dividend on its Common Stock or otherwise makes a distribution on any class of capital stock that is payable in shares of Common
Stock, (ii) subdivides outstanding shares of Common Stock into a larger number of shares, or (iii) combines outstanding shares of Common Stock into 

  

 3 

 
a smaller number of shares, then in each such case the Per Share Warrant Price shall be multiplied by a fraction of which the numerator shall be the number
of shares of Common Stock outstanding immediately before such event and of which the denominator shall be the number of shares of Common Stock outstanding immediately after such event. Any adjustment made pursuant to clause (i) of this
paragraph shall become effective immediately after the record date for the determination of shareholders entitled to receive such dividend or distribution, and any adjustment pursuant to clause (ii) or (iii) of this paragraph shall become
effective immediately after the effective date of such subdivision or combination. 
 (b) If, at any time while this Warrant is outstanding,
(1) the Company effects any merger or consolidation of the Company with or into another person, (2) the Company effects any sale of all or substantially all of its assets in one or a series of related transactions, (3) any tender
offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to tender or exchange their shares for other securities, cash or property, or (4) the Company effects any
reclassification of the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (in any such case, a “Fundamental Transaction”),
then thereafter this Warrant shall represent the right to receive, upon exercise of this Warrant, the same amount and kind of securities, cash or property as it would have been entitled to receive upon the occurrence of such Fundamental Transaction
if it had been, immediately prior to such Fundamental Transaction, the holder of the number of Warrant Shares then issuable upon exercise in full of this Warrant (the “Alternate Consideration”). For purposes of any such exercise, the
determination of the Per Share Warrant Price shall be appropriately adjusted to apply to such Alternate Consideration based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction,
and the Company shall apportion the Per Share Warrant Price among the Alternate Consideration in a reasonable manner reflecting the relative value of any different components of the Alternate Consideration. If holders of Common Stock are given any
choice as to the securities, cash or property to be received in a Fundamental Transaction, then the Holder shall be given the same choice as to the Alternate Consideration it receives upon any exercise of this Warrant following such Fundamental
Transaction. At the Holder’s option and request, any successor to the Company or surviving entity (and, if an entity different from the successor or surviving entity, the entity whose capital stock or assets the Holders of Common Stock are
entitled to receive as a result of such Fundamental Transaction) in such Fundamental Transaction shall, either (1) issue to the Holder a new warrant substantially in the form of this Warrant and consistent with the foregoing provisions and
evidencing the Holder’s right to purchase the Alternate Consideration for the aggregate Per Share Warrant Price upon exercise thereof, or (2) purchase the Warrant from the Holder for a purchase price, payable in cash within five trading
days after such request (or, if later, on the effective date of the Fundamental Transaction), equal to the Black Scholes value of the remaining unexercised portion of this Warrant on the date of such request. The terms of any agreement pursuant to
which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity (and, if an entity different from the successor or surviving entity, the entity whose capital stock or assets the Holders of Common
Stock are entitled to receive as a result of such Fundamental Transaction) to comply with the provisions of this paragraph (b) and insuring that the Warrant (or any such replacement security) will be similarly adjusted upon any subsequent
transaction analogous to a Fundamental Transaction. 
  

 4 

 (c) If, at any time while this Warrant is outstanding, the Company shall issue additional shares of
Common Stock for consideration per share less than the then current market price (determined (a) in the event that the Common Stock is publicly listed, by reference to the closing sales price of the Common Stock on the date of such issue or
(b) in the event that the Common Stock is not publicly listed, by reference to the then current market value of each share of Common Stock as determined by the Board of Directors of the Company in good faith; provided, however, that in the
event of a sale, merger, liquidation, dissolution or winding up of the Company (each, a “Liquidity Event”), current market price means the amount per share payable to the holders of the Common Stock upon the consummation of such Liquidity
Event), then the Per Share Warrant Price of the Warrant Shares shall be reduced, concurrently with such issue, to a price (calculated to the nearest cent) determined by multiplying such Per Share Warrant Price by a fraction, the numerator of which
shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of shares which the aggregate consideration received by the Company for the total number of additional shares of Common Stock so issued would
purchase at the then current fair market price, and the denominator of which shall be the number of shares of Common Stock outstanding immediately prior to such issue plus the number of such additional shares of Common Stock so issued; provided,
however, that no adjustment under this Section 3(c) shall operate to reduce the Per Share Warrant Price of the Warrant Shares to a price that is less than $0.92 per share, representing the closing bid price for one share of the Common Stock
on June 22, 2009. Notwithstanding the foregoing, no adjustment to the Per Share Warrant Price shall be required under this Section 3(c): (i) in connection with the issuance of shares of Common Stock and/or options, warrants or other
Common Stock purchase rights and the Common Stock issued pursuant to such options, warrants or other rights (as adjusted for any stock dividends, combinations, splits, recapitalizations and the like after the date hereof) issued or to be issued
after the date hereof to employees, officers or directors of, or consultants or advisors to the Company or any subsidiary, pursuant to stock purchase, stock option or employee benefit plans or other arrangements that are approved by the board of
directors of the Company; (ii) in connection with a bona fide firm commitment underwritten public offering with a nationally recognized underwriter which generates gross proceeds to the Company in excess of $15 million; (iii) upon
conversion of any options, warrants or other rights to acquire shares of Common Stock that are outstanding on the day immediately preceding the date hereof, provided, however, that the terms of such options, warrants or rights are not amended,
modified or changed on or after the date hereof; or (iv) in connection with shares of Common Stock issued as consideration for the acquisition of another company or business in which the shareholders of the Company do not have a majority
ownership interest, which acquisition has been approved by the board of directors of the Company, provided that after giving effect to such acquisition the Company is the surviving entity. 
 (d) All calculations under this Section 3 shall be made to the nearest cent or the nearest  1
/100th of a share, as applicable. The number of shares of Common Stock outstanding at any given time shall not include shares owned or held by or for the account of the Company. 
 (e) Upon the occurrence of each adjustment pursuant to this Section 3, the Company at its expense will promptly compute such adjustment in
accordance with the terms of this Warrant and prepare a certificate setting forth such adjustment, including a statement of the adjusted Per Share Warrant Price and adjusted number or type of Warrant Shares or other 

  

 5 

 
securities issuable upon exercise of this Warrant (as applicable), describing the transactions giving rise to such adjustments and showing in detail the
facts upon which such adjustment is based. The Company will promptly deliver a copy of each such certificate to the Holder and to the Company’s transfer agent. 
 4. Fully Paid Stock; Taxes. The Company agrees that the shares of Common Stock represented by each and every certificate for Warrant Shares delivered on the exercise of this Warrant shall at the time of such
delivery, be duly authorized, validly issued and outstanding, fully paid and nonassessable, and not subject to preemptive rights or rights of first refusal, and the Company will take all such actions as may be necessary to assure that the par value
or stated value, if any, per share of the Common Stock is at all times equal to or less than the then Per Share Warrant Price. The Company further covenants and agrees that it will pay, when due and payable, any and all Federal and state stamp,
original issue or similar taxes which may be payable in respect of the issue of any Warrant Share or any certificate thereof to the extent required because of the issuance by the Company of such security. 
 5. Registration Under Securities Act. 
 (a) The Holder shall, with respect to the Warrant Shares, have the registration rights set forth in the Registration Rights Agreement. By acceptance of this Warrant, the Holder agrees to comply with the provisions of the Registration Rights
Agreement. 
 (b) Until the later of (i) such time as the Holder shall be eligible to resell all of its Warrant Shares without volume
restrictions pursuant to Rule 144(k) promulgated under the Securities Act (assuming Holder is not an “affiliate” of the Company, as defined in Rule 144), as evidenced by a legal opinion to such effect delivered by the Company’s
counsel and acceptable to each of the Company’s transfer agent and the Holder, or (ii) the date on which all Warrant Shares have been sold under a Registration Statement or pursuant to Rule 144 (“Rule 144”) as promulgated under
the Securities Act, the Company shall use its reasonable best efforts to file with the Securities and Exchange Commission all current reports and the information as may be necessary to enable the Holder to effect sales of the Warrant Shares in
reliance upon Rule 144 promulgated under the Securities Act. 
 6. Investment Intent; Restrictions on Transferability. 
 (a) The Holder represents, by accepting this Warrant that it understands that this Warrant and any securities obtainable upon exercise of this Warrant
have not been registered for sale under Federal or state securities laws and are being offered and sold to the Holder pursuant to one or more exemptions from the registration requirements of such securities laws. Certificates representing Warrant
Shares may bear the restrictive legend set forth on the first page hereof. The Holder understands that the Holder must bear the economic risk of such Holder’s investment in this Warrant and any Warrant Shares or other securities obtainable upon
exercise of this Warrant for an indefinite period of time, as this Warrant and such Warrant shares or other securities have not been registered under Federal or state securities laws and therefore cannot be sold unless subsequently registered under
such laws, or an exemption from such registration is available. 
  

 6 

 (b) The Holder, by such Holder’s acceptance of this Warrant, represents to the Company that such
Holder is acquiring this Warrant and will acquire any Warrant Shares or other securities obtainable upon exercise of this Warrant for such Holder’s own account for investment and not with a view to, or for sale in connection with, any
distribution thereof in violation of the Securities Act. The Holder agrees that this Warrant and any such Warrant Shares or other securities will not be sold or otherwise transferred unless (i) a registration statement with respect to such
transfer is effective under the Securities Act or (ii) such sale or transfer is made pursuant to one or more exemptions from the Securities Act. 
 7. Loss, Theft, Destruction or Mutilation of Warrant. Upon receipt of evidence satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and of indemnity reasonably satisfactory
to the Company, if lost, stolen or destroyed, and upon surrender and cancellation of this Warrant, if mutilated, the Company shall execute and deliver to the Holder, a new Warrant of like date, tenor and denomination. 
 8. Warrant Holder Not Stockholder. This Warrant does not confer upon the Holder any right to vote or to consent to or receive notice as a
stockholder of the Company, as such, in respect of any matters whatsoever, or any other rights or liabilities as a stockholder, prior to the exercise hereof; this Warrant does, however, require certain notices to Holders as set forth herein.

 9. Definitions. In addition to the terms defined elsewhere in this Warrant, the following terms have the following meanings:

 “Assignment” shall mean a notice of assignment substantially in the form of Exhibit A attached hereto. 
 “Business Day” shall mean any day except Saturday, Sunday and any day that is a federal legal holiday or a day on which banking institutions in
the State of New York are authorized or required by law or other governmental action to close. 
 “Common Stock” shall mean the
Common Stock, par value $.001 per share, of the Company, for which the Warrant is exercisable and any securities into which such common stock may hereafter be classified. 
 “Exercise Notice” shall mean a notice substantially in the form of Exhibit C attached hereto. 
 “Holder” shall mean the holder of this Warrant and “Holders” shall mean the holder of this Warrant and the holders of all other Warrants. 
 “Partial Assignment” shall mean a notice of partial assignment substantially in the form of Exhibit B attached hereto. 
 “Permitted Consideration” shall mean cash or other funds immediately available to the Company. 
  

 7 

 “Registration Rights Agreement” shall mean that certain Registration Rights Agreement, dated as
of June 23, 2009, by and between the Company and the parties thereto. 
 “Trading Day” means (i) a day on which the
Common Stock is traded on a Trading Market (other than the OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market, a day on which the Common Stock is traded in the over the counter market, as reported by the OTC
Bulletin Board, or (iii) if the Common Stock is not quoted on the OTC Bulletin Board, a day on which the Common Stock is quoted in the over the counter market as reported by the National Quotation Bureau Incorporated (or any similar
organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in (i), (ii) and (iii) hereof, then Trading Day shall mean a Business Day.

 “Trading Market” shall mean whichever of the New York Stock Exchange, the AMEX, the NASDAQ Global Select Market, the NASDAQ
Global Market, the NASDAQ Capital Market or OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question. 
 “Warrants” shall mean this Warrant, all similar Warrants issued on the date hereof and all warrants hereafter issued in exchange or substitution for this Warrant or such similar Warrants. 
 10. Communication. All notices and communications hereunder shall be in writing and shall be deemed to be duly given if sent by registered or
certified mail, return receipt requested, via a national recognized overnight mail delivery service, or by facsimile (provided the sender receives a machine-generated confirmation of successful transmission), if to the Company, to: 
 eDiets.com, Inc. 
 1000 Corporate Drive

 Suite 600 
 Ft. Lauderdale,
Florida 33334 
 Attn: Chief Executive Officer 
 Tel: 954-703-6347 
 Fax: 954-938-0031 
 With a copy to (except in the case of Exercise Notices, Assignments and Partial Assignments): 
 Edwards Angell Palmer & Dodge LLP 
 1 N. Clematis Street 
 Suite 400 
 West Palm Beach, Florida 33401 
 Attn: Leslie J. Croland 
 Tel: 561-820-0212 
 Fax: 561-655-8719

 If to the Holder of this Warrant, to such Holder at the address listed on the records of the Company. 
  

 8 

 11. Reservation of Warrant Shares; Listing. The Company shall at all times prior to the Expiration
Date (a) have authorized and in reserve, and shall keep available, solely for issuance and delivery upon the exercise of this Warrant, the shares of the Common Stock and other securities and properties as from time to time shall be receivable
upon the exercise of this Warrant, free and clear of all restrictions on sale or transfer, other than under Federal or state securities laws, and free and clear of all preemptive rights and rights of first refusal; and (b) use its reasonable
best efforts to keep the Warrant Shares authorized for listing on any national securities exchange, the Nasdaq National Market, the Nasdaq Capital Market or the OTC Bulletin Board. 
 12. Headings; Severability. The headings of this Warrant have been inserted as a matter of convenience and shall not affect the construction
hereof. In case any one or more of the provisions of this Warrant shall be invalid or unenforceable in any respect, the validity and enforceability of the remaining terms and provisions of this Warrant shall not in any way be affected or impaired
thereby and the parties will attempt in good faith to agree upon a valid and enforceable provision which shall be a commercially reasonable substitute therefor, and upon so agreeing, shall incorporate such substitute provision in this Warrant.

 13. Applicable Law. This Warrant shall be governed by and construed in accordance with the law of the State of Delaware without
giving effect to the principles of conflicts of law thereof. 
 14. Specific Performance. The Company agrees that the remedies at law
of the Holder of this Warrant in the event of any default or threatened default by the Company in the performance of or compliance with any of the terms of this Warrant are not and will not be adequate and that, to the fullest extent permitted by
law, such terms maybe specifically enforced by a decree for the specific performance of any obligation contained herein or by an injunction against a violation of any of the terms hereof or otherwise. 
 15. Amendment, Waiver, etc. Except as expressly provided herein, neither this Warrant nor any term hereof may be amended, waived, discharged or
terminated other than by a written instrument signed by the party against whom enforcement of any such amendment, waiver, discharge or termination is sought. 
 IN WITNESS WHEREOF, the Company has caused this Warrant to be duly signed by its undersigned duly authorized officer as of the Original Issue Date first above referenced. 
  

			
	eDiets.com, Inc.
		
	By:	 	 /s/ Thomas Hoyer

	Name:	 	Thomas Hoyer
	Title:	 	Secretary

  

 9 

 EXHIBIT A 
 ASSIGNMENT 
 FOR VALUE RECEIVED
                         hereby sells, assigns and transfers unto
                                 the foregoing Warrant and all rights evidenced thereby,
and does irrevocably constitute and appoint
                                         
   , attorney, to transfer said Warrant on the books of eDiets.com, Inc. 
  

							
	 Dated:                                
	 		 	Signature:	 	  

				
		 		 	Address:	 	  

  

 10 

 EXHIBIT B 
 PARTIAL ASSIGNMENT 
 FOR VALUE RECEIVED
                                 hereby assigns and transfers unto
                                     the right to purchase
                 shares of the Common Stock, par value $.001 per share, of eDiets.com, Inc. covered by the foregoing Warrant, and a proportionate part of said Warrant
and the rights evidenced thereby, and does irrevocably constitute and appoint
                                        ,
attorney, to transfer that part of said Warrant on the books of eDiets.com, Inc. 
  

							
	 Dated:                                
	 		 	Signature:	 	  

				
		 		 	Address:	 	  

  

 11 

 EXHIBIT C 
 EXERCISE NOTICE 
 The undersigned hereby elects to purchase
                         shares of Common Stock of eDiets.com, Inc. pursuant to the attached Warrant, and, if such Holder is not
utilizing the cashless (or net) exercise provisions set forth in the Warrant, encloses herewith $                 in cash, certified or official bank check or checks or
other immediately available funds, which sum represents the aggregate Per Share Warrant Price for the number of shares of Common Stock to which this Exercise Notice relates, together with any applicable taxes payable by the undersigned pursuant to
the Warrant. 
 By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that it is an “accredited investor”
as defined in Rule 501(a) under the Securities Act of 1933. 
 The undersigned requests that certificates for the shares of Common Stock issuable upon this
exercise be issued in the name of:
                                         
                           . 
  

							
	Date:                     	 		 	  

		 		 	Signature
				
		 		 	Name:	 	  

		 		 	Address:	 	  

		 		 		 	  

			
		 		 	Social Security or Tax I.D. Number:
				
		 		 		 	  

  

 12 

 Exhibit B 
 Form of Registration Rights Agreement 
  

 1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00160-of-00352.parquet"}]]